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Abstract Despite the many proposed advantages related
to nanotechnology, there are increasing concerns as to the
potential adverse human health and environmental effects
that the production of, and subsequent exposure to nano-
particles (NPs) might pose. In regard to human health,
these concerns are founded upon the plethora of knowledge
gained from research relating to the effects observed fol-
lowing exposure to environmental air pollution. It is known
that increased exposure to environmental air pollution can
cause reduced respiratory health, as well as exacerbate pre-
existing conditions such as cardiovascular disease and
chronic obstructive pulmonary disease. Such disease states
have also been associated with exposure to the NP com-
ponent contained within environmental air pollution, rais-
ing concerns as to the effects of NP exposure. It is not only
exposure to accidentally produced NPs however, which
should be approached with caution. Over the past decades,
NPs have been specifically engineered for a wide range of
consumer, industrial and technological applications. Due to
the inevitable exposure of NPs to humans, owing to their
use in such applications, it is therefore imperative that an
understanding of how NPs interact with the human body is
gained. In vivo research poses a beneficial model for
gaining immediate and direct knowledge of human expo-
sure to such xenobiotics. This research outlook however,
has numerous limitations. Increased research using in vitro
models has therefore been performed, as these models
provide an inexpensive and high-throughput alternative to
in vivo research strategies. Despite such advantages, there
are also various restrictions in regard to in vitro research.
Therefore, the aim of this review, in addition to providing a
short perspective upon the field of nanotoxicology, is to
discuss (1) the advantages and disadvantages of in vitro
research and (2) how in vitro research may provide
essential information pertaining to the human health risks
posed by NP exposure.
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Introduction
Over the past twenty years, the increase in nanotoxicology
research has been concomitant with the overwhelming
increase in the level of nanotechnology-related products
being produced (Maynard 2007). This new industrial rev-
olution promises to provide an advantageous basis for
numerous applications, including medicine, consumer
products (such as cosmetics and sporting equipment),
environmental remediation and information technology
(Maynard 2007), and is proposed to have a net worth of
$15 billion by 2015 (Service 2004).
In order to realise these proposed benefits, heightened
research has been performed over the past two decades in
order to determine whether the potential benefits of nano-
technology could be recognised without any adverse
impact upon human health, as well as, most recently, the
environment. This has been aptly termed nanotoxicology.
Based on the principles of toxicology (Timbrell 1999),
nanotoxicology can be defined as ‘the study of the effects
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of nanoparticles (NPs) (either accidentally produced or
engineered) on living organisms’ and described as a mul-
tidisciplinary science including material science, chemis-
try, physics and medicine (Donaldson et al. 2004). The
field of nanotoxicology focuses upon gaining a thorough
understanding of the relationship between properties such
as particle size, surface area and reactivity, dose (concen-
tration), material composition and the potential toxicity of
NPs. In relation to this, it is also proposed that nanotoxi-
cology will develop and implement ‘nano-specific’ proto-
cols in order to investigate and gain the knowledge
necessary in order to determine the potential toxicity of the
plethora of different NPs. In addition to this, it is important
to note that over the past decade, there has been increased
confusion as to the definition of a NP. The International
Organization for Standardization (ISO), has provided
specific definitions in their recent document entitled
‘‘Nanotechnologies – Terminology and definitions for
nanoobjects—Nanoparticle, nanofibre and nanoplate’’. For
the basis of this review, the following definition for a NP; a
nano-object [a material with one, two or three external
dimensions in the nanoscale (1-100 nm)] with all three
external dimensions in the nanoscale (ISO/TS: 27687:
2008); will be used.
The requirement for gaining an understanding of the
potential adverse effects of NP exposure is, in part, based
upon the known effects of exposure to environmental air
pollution. It is well understood that the NP component
contained within environmental air pollution, specifically
particulate matter with a size of 10 lm or less (PM10), can
increase the potential for humans to exhibit increased
pulmonary diseases. However, due to the rapid advent of
new, engineered NPs, as well as what is already known in
regard to exposure to (accidentally produced) NPs within
environmental air pollution, the need to understand the
potential effects of exposure to these nano-sized materials
requires efficient, effective and speedy assessment. This, of
course, would be possible using in vitro testing strategies;
however, the questions remains whether or not such testing
strategies are enough to define what the exact effect would
be in vivo. The aim of this review therefore in addition to
providing a short perspective upon the field of nanotoxoi-
cology is to discuss (1) the advantages and disadvantages
of in vitro research and (2) how in vitro research may
provide essential information pertaining to the human
health risks posed by NP exposure.
Nanotoxicology: a brief perspective
Recently, the field of nanotoxicology has been described as
a multi-interdisciplinary field, consisting of biologists
(including toxicologists), chemists (including biochemists),
physicists, mathematicians and epidemiologists (European
Science Foundation (ESF) Report 2005). This, however, is
not a new concept to the field. Since the first studies that
showed NPs to induce a heightened adverse effect on
biological systems compared to their larger sized counter-
parts at the same mass dose (Ferin et al. 1992; Oberdorster
et al. 1992), the understanding that NPs require a multi-
disciplinary approach (i.e. biology, physics, chemistry and
medicine) has been accepted. Due to the constant increase
in the number, type and sensitivity of equipment being
used to study NPs and their subsequent effects, this multi-
interdisciplinary approach has been significantly improved
in the past few years (Bouwmeester et al. 2010). A com-
plete review of the history and current status of the field of
nanotoxicology is beyond the remit of this overview. In
order to obtain a clear understanding of the field up to the
current moment, it is suggested that such publications as
Oberdorster et al. (2005, 2007), Donaldson et al. (2006),
Stone et al. (2009) and Knol et al. (2009) are considered.
Briefly, however, concern surrounding the exposure of
humans to NPs (mainly) derives from their small size and
emanates from two independent findings that separately
recognised that as particle size decreases, toxicity generally
increases.
One of the initial studies to demonstrate the potentially
harmful effects of exposure to NPs was by Ferin et al.
(1992). In this study, rats were exposed, via inhalation, to
both NP (21 nm diameter) and fine (250 nm diameter)
titanium dioxide (TiO2) particles, as well as intratracheally
instilled with TiO2 particles of various sizes (12, 21, 230
and 250 nm in diameter) over a period of 12 weeks.
Examination of the effects of treatment with each particle
size was then performed over a 70-week post-exposure
period. It was demonstrated that TiO2 NPs promoted an
acute inflammatory response following both intratracheal
instillation and sub-chronic inhalation techniques com-
pared to the larger particles (230 and 250 nm). The
inflammation observed in exposure animals was subse-
quently found to reduce to control levels post-exposure
(64 weeks), with a noted decrease (from peak levels) in the
number of neutrophils present in the lung at this time. NPs
were also found to remain within the lung longer
(501 days) than fine particles (174 days). The prolonged
retention of TiO2 NPs in the lung was suggested to be an
effect of the finding that at equivalent masses, NPs were
able to translocate to the pulmonary interstitium more
efficiently than the larger TiO2 particles. It was suggested
that the translocation of NPs to the interstitium was due to
the smaller particles (12 and 21 nm) not being taken up by
alveolar macrophages and undergoing clearance from the
alveoli via uptake by alveolar type-1 epithelial cells
instead. In addition to this, it was found that an increased
dose (increased number of particles and decreased particle
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size) promoted movement of particles within the pulmon-
ary system. It was also observed that the number of parti-
cles present, particle size, delivered dose and the delivered
dose rate also had an effect on the translocation process.
Ferin et al. (1992) concluded that the observed inflamma-
tion was due to exposure of the NPs to the rat lung,
impaired lung clearance and NP redistribution.
In a subsequent publication, these findings were sup-
ported by Oberdorster et al. (1992), who showed increased
levels of inflammation to be present in the alveolar space of
rats after instillation with 500 lg TiO2 NPs (20 nm) over
24 h, compared to TiO2 fine particles (250 nm) at the same
mass dose. It was also found, in comparison with Ferin
et al. (1992), that NPs were able to enter the interstitium
more readily than the larger TiO2 particles. Oberdorster
et al. (1992) further suggested that the increased inflam-
matory response to acute NP exposure could not be
explained fully by the movement of particles to the inter-
stitium but could be related to the larger surface area of the
particles and their interaction with alveolar macrophages
and interstitial cells. Focusing on alveolar macrophages, it
was noted that they were effective inhibitors of the
inflammatory response to NPs due to the active uptake of
these particles. The findings of both Ferin et al. (1992) and
Oberdorster et al. (1992) prompted increased interest into
the effects of NPs on the lung, as well as the possible health
effects that exposure to NPs might pose to respiratory and
cardiovascular functions (Li et al. 1997, 1999) and why
these effects are observed (Brown et al. 2001; Duffin et al.
2002, 2007; Stoeger et al. 2006).
In addition to these laboratory investigations, epidemi-
ological studies conducted over the last two decades have
shown a positive correlation between the level of partic-
ulate air pollution and increased adverse health effects
(Dockery et al. 1993; Bremner et al. 1999; Braga et al.
2000), including increased pulmonary diseases (Choudhury
1997; Pope and Dockery 1999; Schwartz 2004), as well as
a rise in the number of deaths from cardiovascular disease
(Abbey et al. 1999; Aga et al. 2003; Zanobetti et al. 2003;
Medina et al. 2004; Pope et al. 2009). Additional epide-
miological studies have also reported a direct relationship
between the exposure of NPs in air pollution and adverse
health effects (Peters et al. 1997; Wichmann et al. 2000;
Schulz et al. 2005). Specifically, Peters et al. (1997)
reported that human respiratory ill health was associated
with the number of ambient NPs inhaled. In this study, it
was observed that twenty-seven non-smoking asthmatics,
who resided within a highly polluted city in central
Europe, had a significant decrease in the peak expiratory
flow from their lungs over a 6-month period. It was con-
cluded by Peters et al. (1997) that the adverse health
effects observed following exposure to PM10 could be
related to the size distribution of environmental air
pollution and therefore supporting the theory originally
stated by Seaton et al. (1995) that NPs could potentially
drive toxicity in the lung.
Progress in the field of nanotoxicology has gained
increased intensity since the aforementioned laboratory-
based and epidemiological studies. A prime example of
how the field has changed in the past decade is that it is
now ingrained into researchers within the field that they
must fully understand not only the cellular system they
are using but also the NP suspensions they are using. In
the studies by Ferin et al. (1992) and Oberdorster et al.
(1992), the concept of particle characterisation was
highlighted in their subsequent conclusions (i.e. particle
size); however, understanding the fundamental particle
characteristics was not so pertinent at that time compared
to understanding the effects that the smaller particles had.
Nowadays, however, it is well understood that particle
size and, particularly, the surface area and reactivity
(Brown et al. 2001; Duffin et al. 2002, 2007) are relative
to their effects. It is no longer sufficient to simply suspend
a dry or wet sample of NPs in the suspension vehicle of
choice and then expose the chosen model (i.e. tissue or
cell cultures) to these NPs. The concept for increased NP
characterisation has been based upon reports showing that
NPs can alter their characteristics, such as size, shape,
zeta potential, surface area and reactivity, length, aspect
ratio, chemical composition and surface attachments (such
as the attachment of additional proteins to the surface of
NPs when suspended in cell culture media containing
serum proteins) when in different suspension media and
after alternative preparation techniques. Thus, the particle
suspension originally used and exposed to the experi-
mental model is perhaps not the one interacting with the
model, and so the hypothetical effect observed is possibly
not relative to the original NP suspension used. Therefore,
it is essential that information pertaining to the charac-
teristics of NPs is obtained relative to the experimental
set-up being used.
Although increased attention is now being given to the
specific characteristics of the NPs being used, questions
still arise concerning the specific exposure method
employed relative to the potential exposure route for the
cells used. For example, are suspension cultures suitable
for assessing the effects of inhaled NPs, when exposure
systems are available that can deposit defined doses of
NPs at the air–liquid interface (Tippe et al. 2002; Diabate´
et al. 2008; Lenz et al. 2009; Brandenberger et al. 2010). It
may be argued, however, that suspension cultures are
more beneficially used for the investigation of NPs that are
for use in applications such as medicine and food, which
could enter the human body via injection and ingestion
(Knol et al. 2009). Additionally, suspension cultures
would be beneficial for exposing cells of secondary target
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organs in the human body following their inhalation.
Knowledge of the translocation of NPs following their
inhalation (regarded as the primary exposure route of NPs)
is in its infancy however, and the precise methods needed
to understand this increasing area of nanotoxicology are
yet to be confirmed (Knol et al. 2009). In addition to using
realistic exposure systems, it is also pertinent to highlight
the necessity to use realistic doses. Recent research into
the toxicity of NPs (Ryman-Rasmussen et al. 2009) has
shown detrimental effects of nano-objects over time;
however, the concentrations used have been significantly
higher than what any human would be exposed to. This
parameter is of the upmost importance if the field of
nanotoxicology is going to understand and provide a
realistic knowledge base of NP effects to human health,
which will help the production and use of nanotechnology
applications within both an occupational and consumer
setting.
Despite the need to measure the previously highlighted
parameters and to maintain a realistic aspect to nanotox-
icology research, the precise mechanism of NP toxicology
is still not understood. Currently, the hypothesis that NPs
induce adverse cellular effects via oxidative means (oxi-
dative stress paradigm) (Donaldson et al. 2003) is used as
a basis for many NP investigations. Recently, however,
additional paradigms have been suggested for NPs, such as
the fibre paradigm (Do¨rger et al. 2001; Donaldson and
Tran 2004) and the theory of genotoxicity (Schins
and Knaapen 2007). The fibre paradigm was recently and
perhaps most notably highlighted in the paper by Poland
et al. (2008), in which it was shown that multi-walled
carbon nanotubes caused granulomas in the peritoneal
cavity in vivo. This paradigm, however, can only be
attributed to nanofibres and especially those relating to the
specific characteristics of HARN (high aspect ration
nanoparticles) (Donaldson et al. 2006). Thus, the plethora
of spherical NPs available cannot fit this paradigm. They
may, however, in addition with the fibrous nano-objects fit
into the theory of genotoxicity. This theory has been based
upon numerous testing strategies using NPs [100 nm in
size, with a few actually based upon NPs\100 nm and so
requires increased, in-depth research to fully understand
the ability for NPs to be genotoxic, mutagenic and
potentially carcinogenic.
Due to the increased attention and funding opportunities
provided for nanotoxicology research over the past
5–10 years, there has been an abundance of published
studies claiming to be assessing the effects of NPs in
relation to human health (Oberdorster et al. 2007). In the
majority of these publications, there have been the
advantages of numerous time points, NP types and doses as
well as end-points measured. This has only been possible
due to the use of an in vitro-based testing strategy.
Nanotoxicology testing in vitro
As highlighted earlier, the ability to perform such a mag-
nitude of research, which is required in order to maintain
an even balance of knowledge and understanding of the
effects of NPs compared to the augmented production of
NP-based products and applications, has been specifically
due to the availability of in vitro testing strategies. Simi-
larly, the European Union has promoted the use of in vitro
testing strategies for this reason to investigate the effects of
new cosmetics (European Cosmetics directive; 76/768/
EEC), suggesting specific cell types, such as the human
promyelomonocytic cell U937 (a surrogate dendritic cell
line) for use in exposure and toxicological analyses.
Although any experimental analysis can be performed
with cells obtained from either in vivo experimentation
(ex-vivo) as well as in vitro, it is pertinent to highlight the
constant debate of the advantages and disadvantages of
both in vitro and in vivo. Although in vivo (specifically
mice and rat models, however, also considering research on
hamster, guinea pig and monkey models) research is
known to enable scientific research to observe almost ‘first-
hand’ the effects of a substance as they would occur in a
homosapian, in vitro models provide the possibility to
investigate toxic effects on human cells extensively, which
cannot be conducted in vivo (Rothen-Rutishauser et al.
2008a). Cultured human and animal cells can be better
controlled and therefore yield more reproducible data than
in vivo systems; however, they require a high standardi-
sation to maximise reproducibility.
Commonly, nanotoxicology studies have used mono-
cultures of cells that are specific to organs of the body. For
example, epithelial cells are commonly used, as these form
the basis for many of the natural barriers formed within the
human body. Macrophage cells are used as a model to
study the effects of NPs on the human immune system.
Dendritic cells are also used, however, not as commonly as
macrophages. This is interesting as dendritic cells would,
arguably, provide a more beneficial model for NP–immune
system interactions due to their natural role within the
human body and its innate/adaptive immune systems.
Additionally, specific cells such as C3A and HepG2 cells
are also used for example for the liver, the PC12 cell line is
used for analysis of NPs with the brain, whilst there are
also numerous tumour cell lines that are used, such as
mesothelioma cell lines (e.g. IST-Mes3/2P). In fact, there
are many different cell lines used for every different organ
of the human body. Table 1 provides an example of the
most commonly used human cell lines used in studies
concerning nanotoxicology.
Although monoculture systems provide the basis for
high-throughput analysis for nanotoxicology, they do not
represent a realistic model of how NPs will interact with a
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specific organ of the body. Over the past 5 years, there
have been increased efforts to establish more realistic
models to study the toxic potential of NPs. An example of
such an effort is the triple cell co-culture system composed
of epithelial cell line (A549 or 16HBE14o-), human
monocyte-derived macrophages and dendritic cells that has
been established, simulating the most important barrier
functions of the epithelial airway by Rothen-Rutishauser
et al. (2005). This model provides a clear basis for inves-
tigating the interaction of NPs with the lung (Rothen-
Rutishauser et al. 2005, 2008b) as well as at the air–liquid
interface (Blank et al. 2006, 2007) (Fig. 1). It is also
important to point out that in order to further mimic the
situation in vivo, primary alveolar epithelial cells have
been harvested from human lung biopsies and employed in
place of the epithelial cell lines commonly used in the
triple cell co-culture model (Lehmann et al. 2010).
There are additional co-culture systems also available,
such as the ones reported by Alfaro-Moreno et al. (2008)
and Bhabra et al. (2009). The co-culture system of Alfaro-
Moreno et al. (2008) is in fact a ‘quad-culture’, containing
epithelial, endothelial, macrophage and mast cells, whilst
that of Bhabra et al. (2009) is a bi-culture of BeWo (pla-
cental) and human fibroblast cells. The latter study reported
that cobalt-chromium (CoCr) NPs can indirectly affect the
homoeostasis of fibroblast cells despite being located
behind a confluent layer of BeWo cells. It was suggested by
Bhabra and colleagues that increased DNA damage
Table 1 Human cell culture models used in studies for nanotoxicity
Primary cultures References
Monocyte-derived macrophages (Waldman et al. 2007)
Monocyte-derived dendritic cells (Blank et al. 2007; Rothen-Rutishauser et al. 2007, 2005)
Cell lines
Airway epithelial cells
Calu-3 (Bivas-Benita et al. 2004; Grenha et al. 2007; Rotoli et al. 2008)
16HBE14o- (Brzoska et al. 2004; Holder et al. 2008)
BEAS-2B (Herzog et al. 2007; Jang et al. 2006; Park et al. 2007; Veranth et al. 2007)
Alveolar epithelial cells
A549 (Duffin et al. 2007; Park et al. 2007; Stearns et al. 2001)
Immortalised human alveolar type 2 cells
with alveolar type 1 phenotype
(Kemp et al. 2008)
Macrophages
THP-1 (Chen et al. 2006; Ece et al. 2008; Goulaouic et al. 2008; Wottrich et al. 2004)
Fibroblasts
MRC-9 (Limbach et al. 2005)
Mesothelial cells
MSTO-211H (Kaiser et al. 2008; Wick et al. 2007)
3D cultures
3D aggregates of A549 cells (Carterson et al. 2005)
Triple cell co-culture model (epithelial cells, macrophages,
dendritic cells)
(Rothen-Rutishauser et al. 2007, 2008a, b)
Adapted from Blank et al. (2009)
Fig. 1 Laser scanning microscopy images of the triple cell co-culture
model established by Rothen-Rutishauser et al. (2005). Epithelial
cells (red, volume rendering), human monocyte-derived macrophages
(light blue, surface rendering; black arrows) and human monocyte-
derived dendritic cells (yellow, surface rendering; white arrow) are
shown. The same data set is shown from top (a), from bottom (b) and
without epithelial cells from top (c). Reproduced with permission
from ALTEX (Rothen-Rutishauser et al. 2008b)
Arch Toxicol (2011) 85:723–731 727
123
observed in the human fibroblasts cells following CoCr NP
exposure at 0.036–0.36 mg cm-2 was due to a novel
mechanism in which purine nucleotides are transmitted
through gap juntions, or hemichannels, in the BeWo cell
layer. The study of Bhabra et al. (2009) highlights the
advantages of using in vitro cell co-culture systems, as the
indirect effects reported would not be observed using
monoculture testing strategies, and so therefore without
using such a co-culture system, incorrect information could
be gathered concerning the potential risks of NPs. Despite
these specific examples, numerous laboratories use such
co-culture systems, whether bi-, triple- or quad-cultures.
Additionally, laboratories also use the supernatant taken
from exposed monocultures of one cell type and then use
this to treat a different monoculture cell type. Although this
is not an advantageous co-culture technique, it is a per-
formed practice to gain an understanding of how NPs
interact with different cells over time. It is, however, whilst
there are suitable co-culture systems available that are
cheap (up to 1/10th of the total cost of any in vivo testing
strategy), efficient and easy to construct/use, perhaps a
dated methodology.
One aspect emphasised by the model of Rothen-
Rutishauser et al. (2005) is that the architecture is specific
to that as it is in the human lung (i.e. macrophages on the
apical side, a layer of epithelial cells and dendritic cells on
the basolateral side) (Fig. 1). This type of detail is abso-
lutely essential as it provides a clear sign as to the inter-
action of NPs at the epithelial airway wall. Studies using
co-culture cell systems have reported that they observe
different reactions compared to monoculture analysis
(Mueller et al. 2010; Lehmann et al. 2009); however, such
reactions observed from a culture containing two, three or
four different types of cells merely cultured in the same
dish, (although providing data showing that NPs interact
with different cells in an opposite manner to each cell
monoculture) is not specific to that as it would occur in the
human body. Thus, the architecture of the in vitro cell
co-culture model in regard to the specific organ they rep-
resent is essential. Understanding how the organ works,
taking time to prepare and perform series, upon series of
baseline testing strategies, such as trans-epithelial electrical
resistance (for epithelial layers), understanding the manner
in which the cells interact with one another, the ratio of
different cells to each other cell type in the co-culture, as
well as if the cells remain viable in the co-culture are
essential questions that must be thoroughly investigated
prior to any form of nanotoxicology testing.
As previously highlighted in this review and the studies
referenced, there are a number of different toxicological
endpoints that researchers have used to assess the potential
adverse effects that NPs may have on organs of the human
body. These include numerous different biochemical- and
molecular-based testing strategies, investigating the
potential for NPs to cause cytotoxicity, inflammation,
oxidative stress, cell proliferation and genotoxicity. It is
also important to note that when assessing the potential
toxicity of any form of NP, it is important to investigate
how the particles enter the specific cells being examined
and in which compartments they may be found within (or,
which is also possible, if the NPs stay attached to the cell
membrane). This is of great importance, as it has been
shown that the uptake behaviour can influence the cellular
response following NP exposure (Lovric et al. 2005;
Unfried et al. 2007; Maysinger et al. 2007). As it is not
possible to go into sufficient detail regarding the entry
mechanisms of NPs into cells, it is suggested that Unfried
et al. (2007), as well as Rothen-Rutishauser et al. (2007)
and Muehlfeld et al. (2008a; b) which provide an extensive
overview of these processes, are considered.
In addition to all of the previously mentioned parameters
highlighted in this review that should be taken into con-
sideration when assessing the potential toxicity of NPs (in
relation to the specific experimental question), it is also
vital that additional and appropriate (positive and negative)
controls are used. These are of course relative to the spe-
cific methodology being employed. Although negative
controls are easily identified (usually cell culture medium/
buffer only), determination of the correct positive control
must be given more thought. For example, a low concen-
tration of Triton X100 (such as 0.1 or 0.2%) is able to
provide a clear positive reaction in any lactate dehydro-
genase (LDH) assay (either diagnostic kit, or laboratory
protocol); however, this form of compound would not be
useful when assessing the potential production of reactive
oxygen species by NPs within cells. It is therefore pertinent
that the reaction that the test is causing is debated and the
most adequate and specific positive controls are used.
In addition, testing for false-positive and false-negative
effects within many of the biochemical tests commonly
used in NP toxicology testing is essential to obtain a clear
answer as to their potential adverse effects upon cellular-
based systems. These issues have previously been dis-
cussed in detail by Stone et al. (2009), and it is suggested
that this in-depth review of in vitro toxicology testing
strategies is considered. Examples of such false positive/
negative effects are, however, the ability for proteins to
adsorb to the surface of NPs is realistic and can signifi-
cantly affect the ability for NPs to interact with cellular
systems. It is therefore also essential that the ability for
proteins to adsorb to the surface of particles during toxi-
cological tests is assessed [such as when using an enzyme-
linked immunosorbent assay (ELISA)]. This is also true of
enzymes, such as LDH. It is known that this enzyme can
also adsorb to the surface of NPs, masking their toxicity
and thus providing a false-negative toxic result. As with
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protein adsorption, enzyme adsorption must also be
investigated to correlate valid and representative toxicity
data. Determination of these aspects is easily performed.
Generally, the protocol consists of incubation of the NPs
with the protein/enzyme for a period of time followed by
the specific toxicological test (Clift et al. 2008). Any
adsorption of the proteins or enzymes to the NPs is then
apparent via a loss or increase in the specific protein/
enzyme being measured. Additionally, it is also necessary
to determine the ability for the NPs used to interact with
the assays in regard to the fluorescent dyes or formazans
that are used. An example of this was reported by Worle-
Knirsch et al. (2006), where it was reported that carbon
nanotubes interacted with the MTT formazan (tetrazolium
salt) used and provided a false-negative toxicity. In addi-
tion to this, it is also pertinent that an assessment of the
toxicity of the suspension media/buffer is performed.
Increasingly, NPs are suspended in such buffers as Pluronic
F127 and Tween80 in order to obtain a well-dispersed and
characteristic NP suspension. If, however, a toxic response
is observed following cellular exposure with NPs sus-
pended in such buffers, it is essential that the toxicity of
these buffers is known in order to assess the specific effects
of the NPs only (Wick et al. 2007).
Conclusion
In summary, although the parameters highlighted in this
review can be performed using either in vivo or in vitro
models, due to the heightened level of control/baseline
analysis needed, the advantages of in vitro research enable
such experimental testing strategies beneficial to nanotox-
icology. This, however, will not be sufficiently covered by
only performing monoculture analyses. It is essential that
co-culture systems mimicking the in vivo system are
established and used for the specific organs that are in
danger of interacting with NPs. These systems, however,
will not be able to be completely definitive of the in vivo
situation until further in vivo analyses are performed in
order to confirm the findings of in vitro investigations.
Thus, in conclusion, the future of nanotoxicology testing
lays with in vitro research; however, increased acute and
chronic in vivo research is necessary in order to fulfil this
possibility and to subsequently reduce, refine and replace
all animal experimentation.
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